Please assess the completion status of the following clinical trial:

Trial Title: Helping HIV Infected Patients in South Africa Adhere to Drug Regimens

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* HIV infected~* Viral load greater than 1000 copies/ml~* CD4 count of 200 cells/mm3 or less, or World Health Organization Stage 4 disease~* Living in the area of the study site~* Had a known address for more than 3 months~* Willing to nominate a treatment supervisor (a close family member, sexual partner, friend, or community volunteer) to observe daily ingestion of tablets~* Willing to disclose HIV status to a treatment supervisor and ready to commit to long-term antiretroviral therapy~* Acceptable methods of contraception~Exclusion Criteria:~* Pregnant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Use of a patient nominated peer supporter who will observe the morning dose of ARVs
- 2 (Type: NO_INTERVENTION): Self administration of ARVs

Based on this trial design, predict the completion outcome and termination type (if applicable).